Home / Compare / Clinical trial country use share vs Alzheimer's disease drug trial starts in China Clinical trial country use share vs Alzheimer's disease drug trial starts in China In 2023, clinical trial country use share in China was 15%; alzheimer's disease drug trial starts was 5.
Change the pair
Compare different indicators The series
Over time China, annual figures, spaced by time
. Different units, drawn on separate scales
.
Read the values, not the heights.
Clinical trial country use share
Unit: % · 2 observations
Line chart Clinical trial country use share Clinical trial country use share. 2 observations from 2019 to 2023, ranging from 10% to 15%. Latest value 15% (2023).
%
0
3
6
9
12
15
2019
2020
2021
2022
2023
2024
2025
10%
15%
Clinical trial country use share Clinical trial country use share. 2 observations from 2019 to 2023, ranging from 10% to 15%. Latest value 15% (2023).
%
0
5
10
15
2019
2020
2021
2022
2023
2024
2025
10%
15%
Clinical trial country use share Clinical trial country use share. 2 observations from 2019 to 2023, ranging from 10% to 15%. Latest value 15% (2023).
%
0
5
10
15
2019
2020
2021
2022
2023
2024
2025
10%
15%
View the underlying data Alzheimer's disease drug trial starts
Unit: count · 6 observations
Line chart Alzheimer's disease drug trial starts Alzheimer's disease drug trial starts. 6 observations from 2020 to 2025, ranging from 5 to 16. Latest value 16 (2025).
0
5
10
15
20
2019
2020
2021
2022
2023
2024
2025
6
16
Alzheimer's disease drug trial starts Alzheimer's disease drug trial starts. 6 observations from 2020 to 2025, ranging from 5 to 16. Latest value 16 (2025).
0
5
10
15
20
2019
2020
2021
2022
2023
2024
2025
6
16
Alzheimer's disease drug trial starts Alzheimer's disease drug trial starts. 6 observations from 2020 to 2025, ranging from 5 to 16. Latest value 16 (2025).
0
5
10
15
20
2019
2020
2021
2022
2023
2024
2025
6
16
View the underlying data Shared periods
Side by side Only one period is published for both
series in China as annual figures on the same
basis. Comparing anything else would mean comparing different periods.
Provenance
Where these numbers come from Percentage of total clinical trial country uses accounted for by a given region.
2 observations charted in China
· source organisations: IQVIA
Count of interventional drug or biologic studies in Alzheimer's disease whose start date falls in the period. The region is a site country: a study counts for every country where it lists a site, so regional counts overlap and do not sum to the global count.
6 observations charted in China
· source organisations: ClinicalTrials.gov
Data published under CC BY 4.0 .
Series A as JSON · Series B as JSON